A Phase II first-line study of Carboplatin plus Pemetrexed in elderly patients with advanced non-small, non-squamous cell lung cancer
Phase 2
- Conditions
- on-Small, Non-Squamous Cell Lung Cancer
- Registration Number
- JPRN-UMIN000004635
- Lead Sponsor
- Kochi University, School of Medicine, Department of Hematology and Resporatory Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
1) Squamous cell carcinoma 2) Cases with previous radiation therapy against primary tumor 3) Patients with superior vena cava (SVC) syndrome 4) Patients with severe drug allergy 5) Patients with massive and/or uncontrollable pleural effusion 6) Patients with massive ascites, or pericardial effusion 7) Patients with active severe infections 8) Patients with active lung disease such as interstitial pneumonia or lung fibrosis 9) Patients with symptomatic brain metastasis 10) Patients with active concomitant malignancy 11) Patients with uncontrollable complications such as psychiatric problems 12) Inappropriate patients for this study judged by the physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method response rate
- Secondary Outcome Measures
Name Time Method disease control rate, progression free survival, 1 year survival, safety, quality of life